Lotte G. Zuur

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer.

PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 12, 2026

Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial.

Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial.

Journal: European urology focus

Published: January 24, 2026

Oncological outcomes following PSMA PET/CT-guided salvage whole-pelvis radiotherapy for recurrent prostate cancer.

Oncological outcomes following PSMA PET/CT-guided salvage whole-pelvis radiotherapy for recurrent prostate cancer.

Journal: Clinical and translational radiation oncology

Published: December 23, 2025

Actionable Feedback on Signal-to-Background Ratios During Drop-in Radioguided Surgery.

Actionable Feedback on Signal-to-Background Ratios During Drop-in Radioguided Surgery.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 18, 2025

Anatomical distribution of disease in pN1 prostate cancer with BCR post-RP: A PSMA-PET/CT-based analysis.

Anatomical distribution of disease in pN1 prostate cancer with BCR post-RP: A PSMA-PET/CT-based analysis.

Journal: BJUI compass

Published: September 24, 2025

Oncological Outcomes in Patients with Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-detected Oligometastatic Prostate Cancer Treated with Metastasis-directed Radiotherapy as the Single Treatment Modality.

Oncological Outcomes in Patients with Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-detected Oligometastatic Prostate Cancer Treated with Metastasis-directed Radiotherapy as the Single Treatment Modality.

Journal: European urology oncology

Published: December 10, 2024

99mTcPSMA-radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE-II trial.

99mTcPSMA-radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE-II trial.

Journal: BJU international

Published: February 12, 2024

Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen-targeted Salvage Surgery.

Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen-targeted Salvage Surgery.

Journal: European urology oncology

Published: December 28, 2023

Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options.

Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options.

Journal: Cancers

Published: May 08, 2023

The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?

The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?

Journal: Journal of clinical medicine

Published: March 17, 2023

Endovascular embolization of posttraumatic high-flow priapism: Uncommon arteriovenous fistula of the corpus cavernosum.

Endovascular embolization of posttraumatic high-flow priapism: Uncommon arteriovenous fistula of the corpus cavernosum.

Journal: Radiology case reports

Published: December 30, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026